|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.110 USD | -1.94% |
|
-12.82% | +16.79% |
| Market Cap | 2.36B 2.07B 1.91B 1.76B 3.32B 228B 3.38B 22.84B 8.95B 111B 8.87B 8.67B 384B | P/E 2026 * |
-3.6x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 2.14B 1.98B 1.82B 3.44B 236B 3.49B 23.62B 9.26B 115B 9.17B 8.97B 397B | EV / Sales 2026 * |
3.65x | EV / Sales 2027 * | 3x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -1.94% | ||
| 1 week | -12.82% | ||
| Current month | -8.90% | ||
| 1 month | +1.33% | ||
| 3 months | -4.11% | ||
| 6 months | +36.79% | ||
| Current year | +16.79% |
| 1 week | 8.95 |  | 9.98 |
| 1 month | 8.91 | | 11.22 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 64 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/6/26 | Free | Director | 48,834 | 0.0192% | ||
| 11/6/26 | Free | Director | 48,834 | 0.0192% | ||
| 11/6/26 | Free | Chairman | 48,834 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.94% | -12.82% | +5.81% | +23.78% | 2.36B | |
| +0.21% | -1.34% | +53.17% | +60.65% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -7.43% | +4.35% | +406.96% | 23.48B | |
| +0.74% | +0.73% | -16.23% | -15.55% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -1.15% | +30.12% | -32.02% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.70% | -1.72% | +24.87% | +184.19% | 14.06B | |
| Average | +0.67% | -3.30% | +38.01% | +165.49% | 23.59B | |
| Weighted average by Cap. | +1.44% | -2.43% | +41.11% | +139.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 669M 587M 542M 499M 943M 64.55B 957M 6.47B 2.54B 31.56B 2.51B 2.46B 109B | 726M 636M 588M 541M 1.02B 70.03B 1.04B 7.02B 2.75B 34.24B 2.73B 2.67B 118B |
| Net income | -641M -562M -520M -478M -903M -61.83B -917M -6.2B -2.43B -30.23B -2.41B -2.35B -104B | 141M 123M 114M 105M 198M 13.58B 201M 1.36B 534M 6.64B 529M 517M 22.89B |
| Net Debt | 80.91M 70.9M 65.56M 60.27M 114M 7.8B 116M 783M 307M 3.81B 304M 297M 13.15B | -181M -158M -146M -135M -254M -17.42B -258M -1.75B -685M -8.52B -678M -663M -29.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$9.110 | -1.94% | 2,383,405 |
| 17/07/26 | US$9.290 | +2.03% | 3,272,762 |
| 16/07/26 | US$9.105 | -3.24% | 3,561,547 |
| 15/07/26 | US$9.410 | -3.39% | 6,813,775 |
| 14/07/26 | US$9.740 | -1.72% | 3,968,215 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
